0000950170-24-074838.txt : 20240618 0000950170-24-074838.hdr.sgml : 20240618 20240618160505 ACCESSION NUMBER: 0000950170-24-074838 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240611 FILED AS OF DATE: 20240618 DATE AS OF CHANGE: 20240618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wright Timothy CENTRAL INDEX KEY: 0001383313 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 241051685 MAIL ADDRESS: STREET 1: C/O ANTIGENICS INC STREET 2: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 ownership.xml 4 X0508 4 2024-06-11 0001098972 AGENUS INC AGEN 0001383313 Wright Timothy C/O AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02421 true false false false false Stock Option 13.25 2024-06-11 4 A false 750 0.00 A 2034-01-26 Common Stock 750 750 D Options were granted on January 26, 2024 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 11, 2024. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on January 26, 2025 and the balance vesting in equal quarterly installments thereafter. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 15,000 Stock Options with an exercise price of $0.66. /s/Christine Klaskin, as Attorney-in-Fact for Timothy Wright 2024-06-18